世界の皮膚科治療薬市場予測2019-2028

◆英語タイトル:GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028
◆商品コード:INK20AG009
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年7月
◆ページ数:174
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、皮膚科治療薬の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、薬剤クラス別(抗菌剤、コルチコステロイド、抗ニキビ剤、免疫抑制剤、レチノイド)分析、用途別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・皮膚科治療薬の世界市場規模:薬剤クラス別(抗菌剤、コルチコステロイド、抗ニキビ剤、免疫抑制剤、レチノイド)
・皮膚科治療薬の世界市場規模:用途別
・皮膚科治療薬の世界市場規模:地域別
・企業情報








【レポートの概要】

KEY FINDINGS
The global dermatological therapeutics market is estimated to witness steady growth, projecting a CAGR of 7.54% during the forecast period, 2019-2028. The factors stimulating the growth of the market are the increasing awareness levels of disease progression and origin, and the rising dermatology diseases.

MARKET INSIGHTS
Skin diseases are becoming increasingly prevalent across the globe. Also, the geriatric population worldwide is registering an increasing growth rate. The developing countries are facing the brunt of rising skin diseases, which also impacts the quality of life and productivity. The diseases further result in discrimination due to disfigurement. There is also a growing awareness of disease progression and etiology. The awareness was limited in the past, but at present, many initiatives have been introduced at international and national levels. This is to train the health workers for enhancing treatment, diagnosis, and raise awareness about dermatological conditions. There have also been efforts toward curbing the socio-economic burden of skin diseases. One of the most common dermal disorders is psoriasis, which is a non-communicable autoimmune skin disease.

REGIONAL INSIGHTS
The global dermatological therapeutics market is geographically categorized into North America, Europe, Asia Pacific, and the rest of the world, for growth evaluation. The region of North America contributed majorly to the global market in terms of revenue share in 2019. The growing rate of pores and skin diseases and the rising concentration of dermatology cases in the region, makes North America a primary market.

COMPETITIVE INSIGHTS
The competition between established players is based on product innovation so as to make the most of the untapped market. Some of the eminent layers with their presence established in the market are Amgen Inc, Allergan Inc, Almiral, Bausch Health Companies Inc, AbbVie Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISING LOAD OF DERMATOLOGY DISEASES
3.2.2. RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
3.3. KEY RESTRAINTS
3.3.1. SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY DRUG CLASS
5.1. ANTI-INFECTIVES
5.2. CORTICOSTEROIDS
5.3. ANTI-ACNE
5.4. CALCINEURIN INHIBITORS
5.5. RETINOIDS
5.6. OTHER DRUG CLASSES
6. MARKET BY APPLICATION
6.1. ALOPECIA
6.2. HERPES
6.3. PSORIASIS
6.4. ROSACEA
6.5. ATOPIC DERMATITIS
6.6. ACNE VULGARIS
6.7. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. GERMANY
7.2.3. FRANCE
7.2.4. ITALY
7.2.5. RUSSIA
7.2.6. BELGIUM
7.2.7. POLAND
7.2.8. REST OF EUROPE
7.3. ASIA PACIFIC
7.3.1. CHINA
7.3.2. JAPAN
7.3.3. INDIA
7.3.4. SOUTH KOREA
7.3.5. INDONESIA
7.3.6. THAILAND
7.3.7. VIETNAM
7.3.8. AUSTRALIA & NEW ZEALAND
7.3.9. REST OF ASIA PACIFIC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST & AFRICA
8. COMPANY PROFILES
8.1. ABBVIE INC
8.2. ALLERGAN INC
8.3. ALMIRAL
8.4. AMGEN INC
8.5. BAUSCH HEALTH COMPANIES INC
8.6. GALDERMA
8.7. GLAXOSMITHKLINE PLC
8.8. JOHNSON & JOHNSON
8.9. NOVARTIS AG
8.10. PFIZER INC
8.11. AGI DERMATICS
8.12. LEO PHARMA A/S
8.13. MERCK KGAA

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - DERMATOLOGICAL THERAPEUTICS
TABLE 2: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 3: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 4: GLOBAL ANTI-INFECTIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 5: GLOBAL ANTI-INFECTIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 6: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 7: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 8: GLOBAL ANTI-ACNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN BILLION)
TABLE 9: GLOBAL ANTI-ACNE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 10: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 11: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 12: GLOBAL RETINOIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 13: GLOBAL RETINOIDS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 14: GLOBAL OTHER DRUG CLASSES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 15: GLOBAL OTHER DRUG CLASSES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 16: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 17: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 18: GLOBAL ALOPECIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 19: GLOBAL ALOPECIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 20: GLOBAL HERPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 21: GLOBAL HERPES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 22: GLOBAL PSORIASIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 23: GLOBAL PSORIASIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 24: GLOBAL ROSACEA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 25: GLOBAL ROSACEA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 26: GLOBAL ATOPIC DERMATITIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 27: GLOBAL ATOPIC DERMATITIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 28: GLOBAL ACNE VULGARIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 29: GLOBAL ACNE VULGARIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 30: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 31: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 32: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 33: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 34: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 35: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 36: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 37: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 38: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 39: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 40: REST OF WORLD DERMATOLOGICAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 41: REST OF WORLD DERMATOLOGICAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2019-2028 (IN $ BILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の皮膚科治療薬市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆